| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
C Martin Harris is Director at HSTM, with reported holdings spanning 4 companies. C Martin Harris's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10.4M at current prices.
Our model assigns C Martin Harris a below-average insider score of 39/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -4.5%.
C Martin Harris's largest disclosed position is in TMO as Director, worth about $6.7M. The TMO filings lean toward selling, a net 1,762 shares.
C Martin Harris has 52 Form 4 filings on record from March 2015 to May 2026, across 4 companies: Director at Thermo Fisher Scientific (TMO), 2015–2026; Director at Colgate-Palmolive (CL), 2017–2026; Director at Claritev (CTEV), 2021–2026, and 1 more.
The 70 reported transactions were 29 stock awards, 16 option or other derivative awards, 13 open-market sales and 12 option exercises.
Counted by filing, the open-market trades come to no purchases and 12 sales worth about $1.7M.
The largest open-market sale was 5,703 shares of CL at an average $74.25 on February 21, 2023, about $423K. Twelve months later CL was up 15%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | CL Colgate Palmolive Co | Director | Sale+OE | 2,760 | $84.50 | $233,220.00 | -12.5% | +9.2% | +7.9% | |
| Feb 21, 2023 | CL Colgate Palmolive Co | Director | Sale+OE | 5,703 | $74.25 | $423,446.61 | -25.1% | +5.6% | +14.9% | |
| Feb 2, 2022 | CL Colgate Palmolive Co | Director | Sale+OE | 4,491 | $82.76 | $371,675.16 | -23.5% | -9.5% | -9.3% | |
| Jun 5, 2019 | TMO Thermo Fisher Scientific Inc. | Director | Sell | 275 | $270.73 | $74,451.35 | -4.1% | - | - | |
| May 15, 2019 | HSTM Healthstream Inc | Director | Sell | 1,116 | $25.72 | $28,699.28 | -4.1% | - | - | |
| May 18, 2018 | TMO Thermo Fisher Scientific Inc. | Director | Sell | 206 | $214.43 | $44,173.51 | -3.9% | - | - | |
| May 18, 2018 | HSTM Healthstream Inc | Director | Sell | 525 | $27.63 | $14,504.23 | -2.1% | - | - | |
| May 7, 2018 | HSTM Healthstream Inc | Director | Sell | 3,415 | $26.58 | $90,760.46 | -12.1% | - | - | |
| Mar 1, 2018 | HSTM Healthstream Inc | Director | Sale+OE | 10,452 | $24.06 | $251,487.66 | -29.2% | - | - | |
| Aug 30, 2017 | TMO Thermo Fisher Scientific Inc. | Director | Sell | 360 | $180.97 | $65,149.20 | -6.3% | - | - |